In my view the short, sharp lockdown is warranted. It will give authorities time to discover the extent of exposure from this cluster.
Academic rigour, journalistic flair
Articles on COVID-19
Displaying 4041 - 4060 of 7973 articles
Poor mental health costs the Australian economy up to A$220 billion a year, according to the Productivity Commission. It will take more than piecemeal ‘announceables’ to fix the situation.
In a region and world in flux, Japan and Australia have taken another step towards a formal military alliance.
World Children’s Day is an opportunity to acknowledge children for who they are, the many things they know and what they are capable of right now.
A private market should have no place in the rollout of a COVID vaccine.
We will struggle to find a vaccine that works perfectly for people who need it most, despite what the headlines say is coming in 2021.
Super-spreader events typically have the ‘three Vs" in common: indoor venues, poor ventilation and vocalisation. But many buildings frequented by the public lack ventilation or the means to monitor it.
The funding, procurement, storage and distribution of a vaccine present huge challenges to all governments, including New Zealand’s.
The Brexit Party has become Reform UK. What are they up to now?
Anti-complement drugs have shown promise in treating COVID in several small trials. Larger trials are now underway.
As viruses are transmitted from person to person they are constantly mutating and replicating. Could the SARS-CoV-2 virus evolve to evade the new vaccines that have just been developed?
The pandemic has put a spotlight on a once little-discussed disorder – hoarding. But hoarding disorder is not what you might think.
For-profit colleges’ heavy investment in distance learning has led to a 3% increase in enrollment during the pandemic.
Over US$12 trillion of COVID-19 relief has been promised. If a small portion was put toward economy-boosting green investments, the world could get on track to avoid the worst of climate change.
Moderna’s shot is far easier to store and distribute than Pfizer’s. But there are concerns neither vaccine performs particularly well for older people.
While Chief Scientist Alan Finkel’s review of contact tracing only briefly mentions digital methods, it’s crucial Australia invests in an automated system.
Academics and others concerned with benefitting from peer professional collaboration can use COVID-19 disruptions as an opportunity to improve conferences through smart design.
In the current pandemic, finding the right balance between the protection of public health and respecting civil liberties has proven to be supremely difficult.
The recent vaccine trial results certainly look impressive, but here’s how to fully interrogate what they mean.
Monoclonal antibodies are synthetic molecules manufactured in the lab. But do we need them if a vaccine is on its way?
Job Board
-
PhD Scholarship
-
Senior Lecturer, HRM or People Analytics
-
Senior Research Fellow - Neuromuscular Disorders and Gait Analysis
-
Centre Director, Transformative Media Technologies
-
Postdoctoral Research Fellowship
Top contributors
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Senior Research Fellow in Global Health, University of Southampton
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Medicine, University of East Anglia
-
Associate Professor, School of Population Health, UNSW Sydney
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Medicine, University of Virginia
-
Professor of Public Health, University of Sheffield
